0001209191-20-060227.txt : 20201124
0001209191-20-060227.hdr.sgml : 20201124
20201124164253
ACCESSION NUMBER: 0001209191-20-060227
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201123
FILED AS OF DATE: 20201124
DATE AS OF CHANGE: 20201124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sepp-Lorenzino Laura
CENTRAL INDEX KEY: 0001777421
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39536
FILM NUMBER: 201344674
MAIL ADDRESS:
STREET 1: C/O INTELLIA THERAPEUTICS, INC.
STREET 2: 40 ERIE STREET, SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc.
CENTRAL INDEX KEY: 0001806310
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 843199512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2280 INWOOD ROAD
CITY: DALLAS
STATE: TX
ZIP: 75235
BUSINESS PHONE: (214) 612-0000
MAIL ADDRESS:
STREET 1: 2280 INWOOD ROAD
CITY: DALLAS
STATE: TX
ZIP: 75235
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-23
0
0001806310
Taysha Gene Therapies, Inc.
TSHA
0001777421
Sepp-Lorenzino Laura
C/O TAYSHA GENE THERAPIES, INC.
2280 INWOOD ROAD
DALLAS
TX
75235
1
0
0
0
Stock Option (right to buy)
21.77
2020-11-23
4
A
0
31000
0.00
A
2030-11-23
Common Stock
31000
31000
D
The shares subject to the Option vest in 36 equal monthly installments, subject to the Reporting Person continuing to provide service through each such date.
/s/ Kamran Alam, Attorney-in-Fact
2020-11-24